ABAhlam Badawy

Ahlam Badawy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ahlam Badawy has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Yasser Gamal

    Department of Pediatrics, Faculty of Medicine, Assuit University

    4 shared publications
  • Abdullah Abdel Ghany

    Department of Pediatrics, Faculty of Medicine, Assiut University, Assiut, Egypt

    1 shared publication
  • Ahmed M. Ali

    Department of Pediatrics, Faculty of Medicine, Assiut University, Assiut, Egypt

    1 shared publication
  • Almontaser Hussein

    From the Pediatrics Department, Pediatric Nephrology and Dialysis Unit, Faculty of Medicine, Assiut University Children Hospital, Assiut University, Assiut, Egypt

    1 shared publication
  • Dalia Nigm

    Clinical Pathology Department, Faculty of Medicine, Assiut University, Egypt

    1 shared publication
  • DaliaA Nigm

    Assiut Univ, Fac Med, Dept Clin Pathol, Assiut, Egypt

    1 shared publication

Latest Publications

  • Open Access

    Role of Renal Elastography for the Early Detection of Childhood Glomerulonephritis.

    by Ahlam Badawy, Gehan Mohamed, Noha Mostafa, Momtaz Thabet Allam, Yasser Gamal

    Introduction: Glomerulonephritis is a frequent childhood renal disease, that has diverse underlying etiologies. It has an underlying immunologic mechanism in most cases.Aim of the study: To evaluate renal elastography performance as a diagnostic tool for the early detection of acute childhood glomerulonephritis (AGN) and to determine its role in differentiation of different subtypes of AGN.Methods: This prospective research performed on eighty children separated into 2 groups: Group I: forty cases with clinical and laboratory evidence of glomerulonephritis and Group II: 40 healthy volunteers of comparable age and sex as controls at our University Children Hospital, Paediatric Nephrology Unit from January 2021 to December 2022. Acoustic radiation force impulse (ARFI) elastography was performed to analyse both kidneys in all participantsResults: The comparison of cases &control groups revealed a significant elevation in acoustic radiation force impulse elastography (ARFI-e) measurement values (p0.05).Conclusion: As a bedside easily applicable, non-invasive method for the early detection of acute glomerulonephritis in children, the ARFI-e technique showed promising results that needs further investigation on larger number of different types of AGN. Key words: ARFI-e, Glomerulonephritis, SWS, Elastography

  • Open Access

    Endothelial dysfunction in children with newly diagnosed Graves’ disease

    by Yasser Gamal, Ahlam Badawy, Ahmed M. Ali, Hekma Saad Farghaly, Kotb Abbass Metwalley, Noha Gaber, Momtaz Thabet Allam, Yasser Farouk

    The most frequent cause of hyperthyroidism in children is Graves’ disease (GD). Vascular endothelium is a specific target of thyroid hormone. The purpose of this study is to assess flow-mediated dilatation (FMD)% and serum von Willebrand factor (vWF) levels in children with newly diagnosed GD to reflect the extent of endothelial dysfunction in those children. In this study, 40 children with newly discovered GD and 40 children who were healthy served as the control group. Both patients and controls had anthropometric assessment, as well as measurements of fasting lipids, glucose, insulin, high-sensitivity C-reactive protein (hs-CRP), TSH, and free thyroxine (FT4 and FT3), thyrotropin receptor antibodies TRAbs and vWF. Noninvasive ultrasound was utilized to quantify the carotid arteries’ intima-media thickness and the brachial artery’s FMD. Patients reported significantly reduced FMD response and greater vWF and hs-CRP levels compared to controls (P = 0.001 for each). In multivariate analysis, we reported that vWF was significantly correlated with TSH (OR 2.5, 95% CI 1.32–5.32, P = 0.001), FT3 (OR 3.4, 95% CI 1.45–3.55, P = 0.001), TRAb (OR 2.1, 95% CI 1.16–2.23, P = 0.01), and FMD% (OR 4.2, 95% CI 1.18–8.23, P = 0.001).  Conclusions: Children with newly diagnosed GD have endothelial dysfunction, which is shown by impaired FMD and increased vWF. These findings support the idea that GD may need to be treated as soon as possible. What is Known:• Graves' disease is the most common cause of hyperthyroidism in children.• vWF is a reliable marker for detection of vascular endothelial dysfunction. What is New:• Children with newly diagnosed Graves' disease may have endothelial dysfunction as reflected by impairment of FMD and raised vWF level.• Measurement of vWF level in children with newly diagnosed Graves' disease can be used for early detection of endothelial dysfunction.


  • Open Access

    Effectiveness and Safety of Cyclosporine A in Childhood Nephrotic Syndrome.

    by Ahlam Badawy Ali, Abdullah Abdel Ghany, Mohamed El Tellawy

    Introduction: Cyclosporine A is a calcineurin inhibitor used as an important of line therapy in children with steroid-resistant nephrotic syndrome (SRNS) and as a steroid-sparing agent for children with steroid-dependent nephrotic syndrome (SDNS).However, limited data about its efficacy and side effects in children warrants further evaluation.Methods: In this study, fifty children (who started cyclosporine A drug as a part of their management plan) were included. They were divided into two subgroups, SDNS (29 cases) and SRNS (21cases). Primary end points of the study were to analyze percentage of remission in both groups. In addition, prevelance of cyclosporine side effects were recorded. Results: At the end of the 4th month of cyclosporine therapy, 76.2% of patients of SRNS achieved complete remission. At the end of 12th month, 85.7% of patients achieved complete remission and 14.3 % of them achieved partial remission. In the steroid dependent group, the mean number of relapses over one year was decreased by a percentage of 82.6% after starting cyclosporine treatment. Conclusion: It was concluded that Cyclosporine A is safe and effective to be used in children with steroid resistant nephrotic syndrome. In steroid dependent children, it can be used as a steroid sparing drug reducing the dose of steroid. However, safety of cyclosporine a drug is not absolute, variable degrees of side effects were reported

  • Glomerular Expression of Some Profibrotic Factors in Progressive Childhood Lupus Nephritis

    by Ahlam Badawy, Yasser Gamal, Almontaser Hussein

    Background: Lupus nephritis (LN) is a major cause of mortality and morbidity in both adult and pediatric patients. However, studies regarding pathogenesis and predictors of renal outcomes in childhood LN are limited. Transforming growth factor-β1 (TGF-β1) and Connective tissue growth factor (CTGF) have an important role in proliferative and fibrotic changes in many renal diseases. We aim to evaluate the role of such two profibrotic factors in the progression of childhood onset LN and to detect if their glomerular expression could represent an early predictor of future deterioration of renal function. Methods: 34 children with new onset of LN were included. Glomerular expressions of TGF-β1 and CTGF were evaluated by immunohistochemical analysis in the renal tissue of such patients and in control tissue. GFR was estimated at time of renal biopsy at the onset of LN and after 2 years of follow-up. Rate of GFR change (ΔGFR) was calculated and used as indicative of degree of renal disease progression. Results: Glomerular TGF-β1 and CTGF expressions in children with LN were significantly higher than in control tissue (LN 15.41 ± 9.84 and 15.56 ± 10.51 vs. 2.15 ± 1.45 and 1.35 ± 1.07 in control respectively, with p < 0.001 in both). In addition, the glomerular expressions of TGF-β1 and CTGF were significantly higher in patients with further decline in GFR (20.68 ± 7.73 and 21.05 ± 8.75) versus (5.75 ± 4.37 and 5.50 ± 3.78) in those without change in GFR with ( p = 0.000 for both of them). Conclusions: Patients with LN have increased glomerular expressions of TGF-β1 and CTGF, which were higher in those with further decline in GFR. These profibrotic factors are suspected to be involved in pathogenesis of LN and could be evaluated as a target for therapeutic intervention to stop progression of LN. In addition, their glomerular expression could be used as an early predictor of progression of LN, to justify early aggressive therapy in those with suspected rapid progression.


  • Interleukin 18 as a new inflammatory mediator in left ventricular hypertrophy in children with end-stage renal disease

    by Ahlam Badawy, DaliaA Nigm, Ghada M Ezzat, Yasser Gamal

    Left ventricular hypertrophy (LVH) represents an important determinant of increased cardiovascular morbidity and mortality (CV) in end-stage renal disease (ESRD) patients. The role of inflammatory markers in pathogenesis of LVH in children with ESRD is not fully described. The aim of this study is to evaluate relation of some inflammatory markers [as hs C-reactive protein (hsCRP) and interleukin (IL) 18] with LVH in children with ESRD on regular hemodialysis (HD). This is a cross-sectional study performed on 50 children on regular HD. Demographic data were recorded. Echocardiography was performed at baseline to determine those with LVH. Biochemical parameters: hemoglobin (HB), hsCRP, IL 18, phosphorus, calcium, serum albumin, and lipid profile were evaluated and correlated with LVH. Data were analyzed using Student’s t-test, and logistic regression to determine the relationship between LVH and other variables. LVH was present in 33 (66%) participants. Mean left ventricular mass index was 56.88 ± 22.23 g/m.2.7 Concentric remodeling, concentric hypertrophy, and eccentric hypertrophy were present in 4%, 22%, and 44% of the participants. In univariate analysis, children with LVH had significantly lower levels of HB and serum albumin but higher levels of hsCRP, and IL 18 compared to those without LVH. On multivariate analysis: only hsCRP, and IL 18 were significantly associated with LVH. This study shows that elevated hsCRP and IL-18 are independent determinants of LVH in HD children. Understanding the role of inflammatory molecules in the pathogenesis of LVH in ESRD is important for prediction of high-risk group and implementation of targeted anti-inflammatory therapies.


  • Open Access

    Effect of High Flux Versus Low Flux Hemodialysis on Some Cardiovascular Risk Factors in Egyptian Children with End Stage Renal Disease.

    by Ahlam Badawy, Dalia Nigm, Hekma Farghaly, Yasser Gamal

    Background Cardiovascular disease remains as the main cause of mortality in children with end stage renal disease (ESRD).Among the cardiovascular risk factors, dyslipidemia and inflammation are of great importance as they are both prevalent and modifiable risk factors. We aim to evaluate the effect of permeability of low-flux versus high-flux dialyzer on such 2 factors in children on regular hemodialysis (HD). Patients and Methods 48 children with ESRD were randomized into 2 groups. Group A used low-flux dialyzer, group B used high-flux dialyzer for 6 months. An initial and 6th month blood samples for lipid profile, serum albumin and serum high sensitivity CRP (hs CRP) were obtained. Statistical analysis was done. Results In the high flux group, there was a statistically significant difference in total cholesterol, HDL-cholesterol, triglyceride and hs CRP levels after 6 months when compared to baseline values of the same group, while LDL cholesterol and serum albumin showed no significant change. In the low flux group, results after 6 months didn’t show significant change in previously mentioned parameters when compared with its baseline values of the same group. Comparing these parameters between the 2 groups at 6 months, shows that high flux group has significantly lower total cholesterol, triglyceride, and hs CRP levels. Conclusion This study has demonstrated for the first time improvement of some markers of dyslipidemia and inflammation by using high-flux HD in children with ESRD. These results suggest that high-flux dialysis may benefit such young suffering population by reducing the atherogenic risk, cardiovascular morbidity and mortality.